Guardion Health Sciences, Inc. (NasdaqCM:GHSI) is continuing its strategic review process. Jan Hall, Guardion?s President and Chief Executive Officer, commented in the company?s financial results report for the three months and nine months ended September 30, 2023, ?We are continuing our efforts to build a clinical nutrition platform and the Viactiv® brand. We are also continuing our strategic review process with Alantra, LLC (?Alantra?), our exclusive financial advisor, to evaluate opportunities to maximize stockholder value in the near-term?.

?In the meantime, we believe our market position, consumer loyalty and the extendability of the Viactiv® brand, combined with our current operating business strategy, provide us with a viable platform from which to leverage our resources to continue our efforts to grow operations, improve financial performance and maximize stockholder value,? concluded Ms. Hall.